PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that it has updated the timing of its previously announced fourth quarter 2025 earnings conference call and Investor Day due to significant travel disruptions caused by inclement weather.

GlobeNewsWire • Feb 23, 2026

PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of management will present at two upcoming investor conferences in March.

GlobeNewsWire • Feb 4, 2026

After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million

Chicago Capital sold 377,850 shares of PRCT in the fourth quarter; the estimated transaction value was $12.53 million based on quarterly average pricing. Meanwhile, the quarter-end position value declined by $18.52 million, reflecting both trading and stock price movement.

The Motley Fool • Feb 1, 2026

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, February 24, 2026.

GlobeNewsWire • Jan 26, 2026

Where To Invest In 2026: Top 5 Secular Growth Trends

Every once in a while, a secular trend is so obvious that everyone can see it, and that is the case with AI. Drones are another important secular trend that we believe will benefit many areas of the economy. Robots used to be the province of science fiction movies, but today they are an integral and rapidly expanding area of the economy.

Seeking Alpha • Dec 24, 2025

3 Underrated Robotics Stocks Poised for Huge Gains

The global robotics industry is among the fastest-growing, with projections that it will expand from $50 billion worldwide in 2025 to $111 billion in just five years. Technology develops at a rapid pace, and the full extent of the applications of robotics and automation is still unclear.

MarketBeat • Dec 15, 2025

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

SAN JOSE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 37th Annual Piper Sandler Healthcare Conference in New York City. Management is scheduled to present on Tuesday, December 2 at 8:30 a.m. Eastern Time.

GlobeNewsWire • Nov 20, 2025

Artisan Global Discovery Fund: Q3 Delivers Strong Results Amid Trimming And Exits

The portfolio generated a modestly positive absolute return in Q3, but it trailed the MSCI All Country World Small Mid Index. The Q3 underperformance was driven by stock selection in the IT, financials and consumer discretionary sectors. On the positive side, stock selection in the health care and industrials sectors was the strongest contributor to performance.

Seeking Alpha • Nov 20, 2025

PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript

PROCEPT BioRobotics Corporation ( PRCT ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Matthew Bacso - Vice President of Investor Relations Larry Wood - President, CEO & Director Kevin Waters - Executive VP & CFO Conference Call Participants Matthew O'Brien - Piper Sandler & Co., Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Richard Newitter - Truist Securities, Inc., Research Division Patrick Wood - Morgan Stanley, Research Division Ryan Zimmerman - BTIG, LLC, Research Division Christopher Pasquale - Nephron Research LLC Suraj Kalia - Oppenheimer & Co. Inc., Research Division Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Mason Carrico - Stephens Inc., Research Division Joshua Jennings - TD Cowen, Research Division Brett Gasaway - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Stephanie Piazzola - BofA Securities, Research Division Presentation Operator Good afternoon, and welcome to PROCEPT BioRobotics Third Quarter 2025 Earnings Conference Call.

Seeking Alpha • Nov 5, 2025

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2025.

GlobeNewsWire • Nov 4, 2025